These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment. Bertina RM, Westhoek-Kuipers ME, Alderkamp GH. Thromb Haemost; 1981 Jun 30; 45(3):237-41. PubMed ID: 7281102 [Abstract] [Full Text] [Related]
3. Acquired bleeding disorder in a patient with malignant lymphoma: antibody-mediated prothrombin deficiency. Lee ES, Hibsman BK, Liebman HA. Cancer; 2001 Feb 15; 91(4):636-41. PubMed ID: 11241228 [Abstract] [Full Text] [Related]
4. [Substitution therapy with prothrombin complex concentrates in acquired coagulation disorders]. Fischer M. Wien Klin Wochenschr; 1983 Feb 04; 95(3):82-5. PubMed ID: 6858171 [Abstract] [Full Text] [Related]
5. Crystallization of an anti-factor IX antibody and its complex. Shi X, Li Y, Bian C, Zhao G, Huang M. Acta Crystallogr D Biol Crystallogr; 2005 Jun 04; 61(Pt 6):701-3. PubMed ID: 15930624 [Abstract] [Full Text] [Related]
6. Transient hemorrhagic diathesis associated with an inhibitor of prothrombin with lupus anticoagulant in a 1 1/2-year-old girl: report of a case and review of the literature. Lee MT, Nardi MA, Hadzi-Nesic J, Karpatkin M. Am J Hematol; 1996 Apr 04; 51(4):307-14. PubMed ID: 8602632 [Abstract] [Full Text] [Related]
7. Contributions of Gla and EGF-like domains to the function of vitamin K-dependent coagulation factors. Stenflo J. Crit Rev Eukaryot Gene Expr; 1999 Apr 04; 9(1):59-88. PubMed ID: 10200912 [Abstract] [Full Text] [Related]
8. Improved procedures for the purification of selected vitamin K-dependent proteins. Novoa E, Seegers WH, Hassouna HI. Prep Biochem; 1976 Apr 04; 6(5):307-38. PubMed ID: 787972 [Abstract] [Full Text] [Related]
14. [Acquired haemophilia B: a case report and literature review]. Jedidi I, Hdiji S, Ajmi N, Makni F, Masmoudi S, Elloumi M, Kallel C. Ann Biol Clin (Paris); 2011 Sep 04; 69(6):685-8. PubMed ID: 22123568 [Abstract] [Full Text] [Related]
15. [A patient with hemorrhage originating from an unknown coagulation pathway inhibitor]. Komiyama Y, Munakata M, Masuda M, Kagawa H, Fukuhara S, Takahashi H. Rinsho Byori; 2000 Dec 04; 48(12):1086-92. PubMed ID: 11215416 [Abstract] [Full Text] [Related]
16. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety. Herring SW, Abildgaard C, Shitanishi KT, Harrison J, Gendler S, Heldebrant CM. J Lab Clin Med; 1993 Mar 04; 121(3):394-405. PubMed ID: 8445288 [Abstract] [Full Text] [Related]
17. Activated prothrombin concentrate for patients with factor VIII inhibitors. Kurczynski EM, Penner JA. N Engl J Med; 1974 Jul 25; 291(4):164-7. PubMed ID: 4834485 [No Abstract] [Full Text] [Related]
18. Acquired haemophilia A: errors in the diagnosis. Kazmi MA, Pickering W, Smith MP, Holland LJ, Savidge GF. Blood Coagul Fibrinolysis; 1998 Oct 25; 9(7):623-8. PubMed ID: 9863711 [Abstract] [Full Text] [Related]
19. Acquired factor XIII inhibitor: clinical features, treatment, fibrin structure and epitope determination. Luo YY, Zhang GS. Haemophilia; 2011 May 25; 17(3):393-8. PubMed ID: 21323797 [Abstract] [Full Text] [Related]
20. Editorial: Factor VIII inhibitors. Deykin D. N Engl J Med; 1974 Jul 25; 291(4):205. PubMed ID: 4834491 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]